Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.

@article{Jones2005GeneticLO,
  title={Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.},
  author={Dana Jones and N. Parkin and Sarah E. Hudelson and Laura A. Guay and Philippa Musoke and Francis A Mmiro and Jay Brooks Jackson and Susan H Eshleman},
  journal={AIDS research and human retroviruses},
  year={2005},
  volume={21 4},
  pages={319-24}
}
The HIVNET 012 trial in Uganda demonstrated that a regimen of single-dose nevirapine (NVP) can prevent HIV-1 mother-to-child transmission. Previous studies show that HIV-1 with one or more NVP resistance (NVPR) mutations can be selected in many women as early as 7 days after single-dose NVP. We evaluated the genetic linkage of NVPR mutations in plasma from… CONTINUE READING